Particulate Coated Hydrogel Microparticles Aggregation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Gelatin microspheres tend to aggregate in aqueous solutions due to strong intermolecular interactions, making it challenging to suspend them homogeneously, which hampers their use in large-scale tissue engineering and drug delivery applications.

Innovation Solution

The development of particulate coated hydrogel microparticles with a hydrogel inner core and a porous particulate shell formed using a reverse Pickering emulsion process, where solid nanoparticles inhibit aggregation and allow controlled release of bioactive agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If gelatin microspheres are used for drug delivery and tissue engineering, then they provide excellent biocompatibility and drug loading capability, but they aggregate in aqueous solutions due to strong intermolecular interactions

Engineering Contradiction:
Improvebiocompatibility and drug loading capabilityVSAvoidaggregation in aqueous solution
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces a porous shell layer as an intermediary between the gelatin microspheres and the aqueous environment. This shell acts as a mediator that prevents direct intermolecular interactions between gelatin microspheres while allowing drug molecules to pass through via diffusion, thus resolving the contradiction between maintaining biocompatibility and preventing aggregation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite microsphere structure consisting of a gelatin core and a porous shell layer. This composite design combines the advantages of gelatin (biocompatibility, drug loading) with the advantages of the porous shell (aggregation prevention, controlled release), thereby resolving the technical contradiction.

Inventive Principle:
Principle #40Composite materials

2Stability of the object's composition

If a shell coating is applied to prevent gelatin microspheres aggregation, then aggregation is reduced, but the shell inhibits penetration of drug payloads resulting in insufficient loading and releasing

Engineering Contradiction:
Improveaggregation preventionVSAvoiddrug loading and releasing efficiency
Core Design Contradiction:
Stability of the object's compositionVSQuantity of substance

Solution Approach 1:

The patent employs a porous shell structure instead of a dense coating. The porous structure provides sufficient mechanical support to prevent aggregation while maintaining high permeability to drug molecules. The porosity allows drug payloads to freely penetrate the shell for loading and diffuse through it for controlled release, resolving the contradiction between aggregation prevention and drug delivery efficiency.

Inventive Principle:
Principle #31Porous materials

3Stability of the object's composition

If traditional crosslinking is performed to reduce intermolecular interactions, then some aggregation is reduced, but it does not well prevent gelatin microspheres from aggregation and may affect drug release

Engineering Contradiction:
Improveaggregation reductionVSAvoiddrug release efficiency
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent segments the microsphere structure into two distinct functional zones: a gelatin core for drug loading and a porous shell for aggregation prevention. This segmentation allows each component to perform its specific function optimally without interfering with the other, unlike crosslinking which affects the entire microsphere structure and may hinder drug release.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The particulate coated hydrogel microparticles effectively prevent aggregation, enhance cell function support, and improve drug release, enabling their use in large-scale tissue constructs and drug discovery applications with sustained and controlled bioactive agent delivery.

Implementation Method 1

The particulate coated hydrogel microparticles can be formed using a reverse Pickering emulsion process that assembles the solid particles onto outer surfaces of hydrogel microparticles of an emulsion

Methodology Applied
Scientific EffectPickering emulsion: Emulsion

Implementation Method 2

The porous particulate shell can inhibit aggregation of the microparticles in an aqueous medium

Methodology Applied
Scientific EffectSteric stabilization:

Implementation Method 3

The particulate shell can allow release of the bioactive agents from the hydrogel inner core in a sustained, controlled, and/or predetermined manner

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 4

the porous particulate shell defined by a plurality of solid nanoparticles

Methodology Applied
Scientific EffectPermeation: Permeation

Data Source

PatentUS11944716B2Particulate coated hydrogel microparticles
Publication Date: 2024.04.02 CASE WESTERN RESERVE UNIV
  • US11944716B2 patent drawing
  • US11944716B2 patent drawing
  • US11944716B2 patent drawing

AI summary

A composition includes a plurality of particulate coated hydrogel microparticles, each of the microparticles including a hydrogel inner core and a particulate shell defined by a plurality of solid nanoparticles, the particulate shell inhibiting aggregation of the microparticles in an aqueous medium and being permeable to allow release of agents from the hydrogel inner core.